Treating inflammation is the next big breakthrough in fighting vascular disease. Our therapeutic antibody PC-mAb is a first-in-class candidate.
Follow me is only possible for registered members of the Apex Multiverse
Log in If you are not yet registered ? Register now free of charge Free Registration
| No follow |
